Optimal control for HIV treatment

Apart from the traditional role of preventing progression from HIV to AIDS, antiretroviral drug therapy (ART) has been shown to have the additional benet of substantially reducing infectiousness in infected people, making ART potentially an important strategy in the ght against HIV. We developed a mathematical model based on the WHO's 5-stage classication of HIV/AIDS disease progression. Our model straties the population by disease stage, diagnosis and treatment. We used optimal control methods and data from South Africa to determine the best time-dependent treatment allocation required to minimize new infections, infection-years, deaths and cost. Our results indicated that the treatment strategy to minimize infection-years and new infections is to place emphasis on early treatment (i.e., treatment in Stage II & III), while to minimize cost and death, the emphasis should be on late treatment (i.e., Stage III & IV). Applying the optimal treatment strategy also leads to a substantial reduction in disease incidence and prevalence. The results of this study will hopefully provide some guidance for policymakers in determining how to best allocate antiretroviral drugs in order to maximize the benets of treatment.